SEC Form 4 · accession 0000899243-18-031732
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nitya G. Ray
Officer — See Remarks
Period of report
Dec 22, 2018
Accepted (ET)
Dec 26, 2018 · 6:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.48 | Dec 22, 2018 | A | 400,000 | A | — | Dec 22, 2028 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1The options vest in three equal annual installments commencing on November 16, 2019.
Remarks
Chief Technology Officer Head of Process Sciences, Manufacturing and Supply Chain